Düsseldorf, March 9, 2022 DermaTools Biotech GmbH and its financial investor CytoTools AG conclude settlement agreement after months of negotiations Rellermeyer represents the managing shareholders of DermaTools Biotech GmbH and former board members of CytoTools AG With a settlement agreement dated 08.03.2022, DermaTools Biotech GmbH and its financial investor CytoTools AG have settled disputes which had arisen among […]